Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FEGMK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,667
Award facts
- Contract value 100% obligated
- $33,667.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,667.05 delivery order to AmerisourceBergen Drug Corp for Dupixent (dupilumab) 300 mg/2 mL pen injectors on August 19, 2025, with an ultimate completion date of August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The contract represents a procurement of this specialty pharmaceutical product, which is commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps in military and federal healthcare populations.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards with DLA and other defense healthcare entities, demonstrating its capability to fulfill specialized pharmaceutical procurement requirements for the Department of Defense and related federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FEGMK?
SPE2DB25FEGMK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FEGMK worth?
The government has obligated $33,667 on SPE2DB25FEGMK.
Is contract SPE2DB25FEGMK an order under another contract?
Yes. SPE2DB25FEGMK is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEGMK competed?
The extent of competition for SPE2DB25FEGMK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award